V-Square Quantitative Management’s Teva Pharmaceuticals TEVA Stock Holding History

V-Square Quantitative Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$345K	Sell	10,179 -13,111	-56%	-$437K	0.03%	423
2026 Q1	$701K	Buy	23,290 +1,080	+5%	+$34.7K	0.07%	232
2025 Q4	$693K	Hold	22,210	–	–	0.07%	233
2025 Q3	$449K	Hold	22,210	–	–	0.08%	152
2025 Q2	$372K	Hold	22,210	–	–	0.05%	360
2025 Q1	$341K	Buy	22,210 +2,408	+12%	+$43K	0.05%	389
2024 Q4	$439K	Buy	19,802 +3,549	+22%	+$64.6K	0.06%	325
2024 Q3	$293K	Hold	16,253	–	–	0.04%	427
2024 Q2	$263K	Buy	+16,253	New	+$250K	0.04%	394

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

V-Square Quantitative Management's TEVA Position: Q2 2026 in Review

V-Square Quantitative Management reduced its Teva Pharmaceuticals (TEVA) stake by 56% in Q2 2026, selling an estimated $437K and leaving 10,179 shares worth $345K. The position accounts for 0.03% of the portfolio, ranked #423.

V-Square Quantitative Management first reported a position in TEVA in Q2 2024 and has held it in 9 quarters since. The position peaked at $701K in Q1 2026. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

V-Square Quantitative Management held 10,179 shares of Teva Pharmaceuticals worth $345K as of Q2 2026.
V-Square Quantitative Management sold 13,111 Teva Pharmaceuticals shares in Q2 2026, an estimated $437K.
Teva Pharmaceuticals made up 0.03% of V-Square Quantitative Management's portfolio in Q2 2026, its #423 holding.
V-Square Quantitative Management first reported a position in Teva Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
V-Square Quantitative Management's Teva Pharmaceuticals position peaked at $701K in Q1 2026.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.